Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$BMRN, $ILMN, $NOC, $SIG, $SQ

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Wednesday, as follows:

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was reiterated as Buy and the price target was raised to 113 from 105 at Canaccord Genuity. Shares trade in a 52-wk range of 75.81 – 104.46.

Illumina Inc. (NASDAQ:ILMN) was reiterated as Buy and the price target was raised to 340 from 330. Deutsche Bank also reiterated its Buy rating and raised its target to 330 from 280.

Northrop Grumman Corp. (NYSE:NOC) was raised to Buy from Neutral and the price target was raised to 371 from 246 at Buckingham Research.

Signet Jewelers Ltd. (NYSE:SIG) was downgraded to Neutral from Buy at Nomura.

Square Inc. (NYSE: SQ) was maintained as Buy and the price target was raised to 72 from 66 at Stifel.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH